Results 181 to 190 of about 47,680 (217)

Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Purpose Treatment adherence is a key determinant of outcomes in cancer patients and is influenced by multiple clinical and social factors. Hearing loss (HL) may contribute to communication barriers and treatment disruption. This study aimed to evaluate the relationship between HL and treatment adherence.
Bilgeşah Kılıçtaş   +8 more
wiley   +1 more source

Long‐Term Outcomes of Deep Brain Stimulation in Woodhouse–Sakati Syndrome

open access: yesMovement Disorders, Volume 41, Issue 6, Page 1427-1433, June 2026.
Abstract Background Woodhouse–Sakati syndrome (WSS) is a rare autosomal recessive disease with distinctive neuroendocrine manifestations, with dystonia being the most common. No clear guidelines are available for the treatment of dystonia in WSS. Objective The aim was to analyze the impact of deep brain stimulation (DBS) on WSS‐associated dystonia ...
Hend Alhodaif   +5 more
wiley   +1 more source

SARS-CoV-2 infection and profound hearing loss: much more than a coincidence. [PDF]

open access: yesEinstein (Sao Paulo)
Albernaz PLM, Costa SSD, Nitz VO.
europepmc   +1 more source

Association of a Homozygous TYMP c.131G>C Variant With MNGIE in a Chinese Pedigree: Insights From Genetic Analysis and Computational Modeling

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 6, June 2026.
Researcher highlight: Extending beyond the recently reported compound heterozygous case, we report the same TYMP c.131G>C variant in a homozygous configuration, delivering key genetic evidence for its standalone pathogenicity in MNGIE. ABSTRACT Background Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder ...
Ling Li   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy